VBLT Vascular Biogenics Ltd.

Vascular Biogenics Ltd is a clinical-stage bio-pharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

As of 10/18/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  10/01/2014
Outstanding shares:  62,368,457
Average volume:  146,255
Market cap:   $137,834,290
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    M96883109
Valuation   (See tab for details)
PE ratio:   -5.09
PB ratio:   2.53
PS ratio:   178.77
Return on equity:   -48.96%
Net income %:   -3,546.69%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy